Skip navigation
Indian Literature Database on Communication Disorders

Indian Literature Database
on Communication Disorders

Smiley face


Home


Categories &
Resource Types


Author


Title


Year


Subject


Login/Register

Please use this identifier to cite or link to this item: http://localhost:8080//handle/123456789/783
Title: Effect of Intravenous Administration of Steroids in the Management of Sudden Sensori-Neural Hearing Loss: Our Experience
Authors: Raghunandhan, S
Agarwal, Anoop Kumar
Natarajan, Kiran
Murali, Sathiya
Anand Kumar, R S
Kameswaran, Mohan
Keywords: Sudden sensori-neural hearing loss (SSNHL)
Issue Date: 2013
Journal Name: Indian Journal of Otolaryngology and Head & Neck Surgery
Volume No.: 65
Issue No.: 3
Pages: 229-233
Abstract: The aim of this study was to investigate the efficacy and outcomes of intravenous high dose steroids in patients diagnosed with sudden sensori-neural hearing loss (SSNHL). The study also looked at the various co-morbidities influencing the outcomes of IV steroid therapy and also evaluated the improvement in associated symptoms like vertigo and tinnitus. This prospective study involved 30 patients treated during the 1 year period from January 2010 to 2011 in the Department of Otolaryngology, Madras ENT Research Foundation, Chennai. Male: female ratio was 1.3:1 and age range was 19–80 years. For all patients, pre treatment pure tone audiometry (PTA) was compared with post treatment PTA at 1 month. Treatment was given in the form of intravenous high dose methyl prednisolone. The patients were divided into two groups. Group 1 (20 pts) included SSNHL with no co-morbidity, group 2 (10 pts) included SSNHL with various co-morbidities. The mean hearing level improved from an average of 79.53 dB (HL) before treatment to 42.33 dB (HL) after treatment. In patients with predominantly low frequency HL (16 pts) PTA improved from 76.01 to 32.6 dB while in high frequency HL PTA improved from 83.55 to 53.43 dB. In our study of 30 patients, complete recovery occurred in 56.66% cases and marked improvement (>30 dB) in 16.66% patients. There was no improvement in 26.66% cases. Patients in group 2 had co-morbid factors like diabetes mellitus, dys-thyroidism and hypertension. A statistically significant improvement in the associated symptoms of tinnitus/vertigo, were also noted after IV steroid treatment. According to our results, emergency administration of high dose of Intra-venous corticosteroids to patients with SSNHL is highly recommended. Patients with high frequency preservation have better hearing improvement at the end of treatment. The critical time period for commencing IV treatment is less than 6 h from onset of hearing loss in order to restore normal hearing. High dose Intravenous steroids are a safe and effective treatment in sudden sensori-neural hearing loss.
URI: http://localhost:8080/xmlui/handle/123456789/783
ISSN: 2231-3796
Appears in Resource:Journal Articles

Files in This Item:
There are no files associated with this item.
Show full item record


Items in Database are protected by copyright, with all rights reserved, unless otherwise indicated.